Weiss Multi Strategy Advisers LLC Abb Vie Inc. Call Options Transaction History

Weiss Multi Strategy Advisers LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $389,250 - $480,050	5,000 New	5,000 $461,000
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $897,800 - $1.06 Million	-10,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $920,100 - $1.23 Million	10,000 New	10,000 $947,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.